Effects of two butyrophenone compounds on acute schizophrenic patients: speculation on the neurophysiologic sites of action.
D000208:Acute Disease; D000928:Antidepressive Agents / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009069:Movement Disorders / Q000139:chemically induced; D012559:Schizophrenia / Q000188:drug therapy*; D014272:Trifluperidol / Q000627:therapeutic use
D000928:Antidepressive Agents; D006220:Haloperidol; D014272:Trifluperidol; D002746:Chlorpromazine